Clinical Trial Update: Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating inositol to prevent colorectal cancer in patients with colitis-associated dysplasia was terminated; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Crohn Disease
• Rectal Cancer
• Ulcerative Colitis

Drugs mentioned

• Inositol (inositol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Carcinoma, Dysplasia in Crohn Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-07-12